4//SEC Filing
UVEGES GEORGE 4
Accession 0001209191-18-018913
CIK 0001123494other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:26 PM ET
Size
5.6 KB
Accession
0001209191-18-018913
Insider Transaction Report
Form 4
UVEGES GEORGE
Director
Transactions
- Sale
Common Stock
2018-03-07$4.61/sh−35,054$161,599→ 163,028 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 114,528 shares of common stock held by the Reporting Person.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001124927
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:26 PM ET
- Size
- 5.6 KB